Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Rozenfeld, Raphael ^a   Bushlin, Ittai ^a   Gomes, Ivone ^a   Tzavaras, Nikos ^a   Gupta, Achla ^a   Neves, Susana ^a   Battini, Lorenzo ^a   Gusella, G Luca ^a   Lachmann, Alexander ^a   Ma'ayan, Avi ^a   Blitzer, Robert D ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTIN 3; CANNABINOID 1 RECEPTOR; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; RETINA S ANTIGEN; UNCLASSIFIED DRUG; ARRESTIN3; CANNABINOID; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; EMBRYO; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BRAIN CORTEX; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; NERVE CELL; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TRANSPORT;

RODENTIA;

ANIMALS; APOPTOSIS; ARRESTINS; CANNABINOIDS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CEREBRAL CORTEX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; NEURONS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 84855317125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029239     Document Type: Article

References (49)

1. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, et al. (2007) Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316: 1212-1216.
2. Harkany T, Keimpema E, Barabas K, Mulder J, (2008) Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286: S84-90.
3. Guzman M, Sanchez C, Galve-Roperh I, (2002) Cannabinoids and cell fate. Pharmacol Ther 95: 175-184.
4. Bromberg KD, Ma'ayan A, Neves SR, Iyengar R, (2008) Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 320: 903-909.
5. Harkany T, Guzman M, Galve-Roperh I, Berghuis P, Devi LA, et al. (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28: 83-92.
6. Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, et al. (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J 23: 3020-3029.
7. Mackie K, Hille B, (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci U S A 89: 3825-3829.
8. Mackie K, Lai Y, Westenbroek R, Mitchell R, (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15: 6552-6561.
9. Ma'ayan A, Jenkins SL, Barash A, Iyengar R, (2009) Neuro2A differentiation by Galphai/o pathway. Sci Signal 2: cm1.
10. Jin W, Brown S, Roche JP, Hsieh C, Celver JP, et al. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci 19: 3773-3780.
11. Cichewicz DL, Cox ML, Welch SP, Selley DE, Sim-Selley LJ, (2004) Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats. Eur J Pharmacol 504: 33-38.
12. Manzanares J, Corchero J, Fuentes JA, (1999) Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res 839: 173-179.
13. Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, et al. (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22: 1146-1154.
14. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
15. Rios C, Gomes I, Devi LA, (2006) mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148: 387-395.
16. Bushlin I, Rozenfeld R, Devi LA, Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol 10: 80-86.
17. Dill JA, Howlett AC, (1988) Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. J Pharmacol Exp Ther 244: 1157-1163.
18. Law PY, Koehler JE, Loh HH, (1982) Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines. Mol Pharmacol 21: 483-491.
19. Shapira M, Gafni M, Sarne Y, (1998) Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells. Brain Res 806: 26-35.
20. Rubovitch V, Gafni M, Sarne Y, (2004) The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells. Brain Res Mol Brain Res 120: 138-144.
21. Korzh A, Keren O, Gafni M, Bar-Josef H, Sarne Y, (2008) Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell. Brain Res 1189: 23-32.
22. Berrendero F, Maldonado R, (2002) Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163: 111-117.
23. Berrendero F, Mendizabal V, Murtra P, Kieffer BL, Maldonado R, (2003) Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice. Eur J Neurosci 18: 2197-2202.
24. Uriguen L, Berrendero F, Ledent C, Maldonado R, Manzanares J, (2005) Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. Eur J Neurosci 22: 2106-2110.
25. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, et al. (2007) Conformation-state sensitive antibodies to G-protein-coupled receptors. J Biol Chem 282: 5116-5124.
26. Cvejic S, Trapaidze N, Cyr C, Devi LA, (1996) Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J Biol Chem 271: 4073-4076.
27. Decaillot FM, Befort K, Filliol D, Yue S, Walker P, et al. (2003) Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol 10: 629-636.
28. Rozenfeld R, Devi LA, (2008) Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. Faseb J 22: 2311-2322.
29. Fedorova E, Battini L, Prakash-Cheng A, Marras D, Gusella GL, (2006) Lentiviral gene delivery to CNS by spinal intrathecal administration to neonatal mice. J Gene Med 8: 414-424.
30. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, et al. (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243-252.
31. Gomes I, Filipovska J, Devi LA, (2003) Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods Mol Med 84: 157-183.
32. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, et al. (2000) Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 20: RC110.
33. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3: ra54.
34. Smith ER, Smedberg JL, Rula ME, Xu XX, (2004) Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. J Cell Biol 164: 689-699.
35. Gupta A, Devi LA, (2006) The use of receptor-specific antibodies to study G-protein-coupled receptors. Mt Sinai J Med 73: 673-681.
36. Rozenfeld R, Devi LA, (2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. Faseb J 21: 2455-2465.
37. Hirst J, Robinson MS, (1998) Clathrin and adaptors. Biochim Biophys Acta 1404: 173-193.
38. Rozenfeld R, Type I cannabinoid receptor trafficking: all roads lead to lysosome. Traffic 12: 12-18.
39. Fan SF, Shen KF, Scheideler MA, Crain SM, (1992) F11 neuroblastoma x DRG neuron hybrid cells express inhibitory mu- and delta-opioid receptors which increase voltage-dependent K+ currents upon activation. Brain Res 590: 329-333.
40. Coutts AA, Anavi-Goffer S, Ross RA, MacEwan DJ, Mackie K, et al. (2001) Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci 21: 2425-2433.
41. Hong MH, Xu C, Wang YJ, Ji JL, Tao YM, et al. (2009) Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J Neurochem 108: 102-114.
42. Luttrell LM, Lefkowitz RJ, (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115: 455-465.
43. Shankar H, Michal A, Kern RC, Kang DS, Gurevich VV, et al. (2010) Non-visual arrestins are constitutively associated with the centrosome and regulate centrosome function. J Biol Chem 285: 8316-8329.
44. Molla-Herman A, Boularan C, Ghossoub R, Scott MGH, Burtey A, et al. (2008) Targeting of beta-arrestin 2 to the centrosome and primary cilium: role in cell proliferation control. PlosOne 3: e3728 doi:10.1371/journal.pone.0003728.
45. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ, (2009) beta-arrestin2 mediates anti-apoptotic signaling through regulation of bad phosphorylation. J Biol Chem.
46. Bergmann A, (2002) Survival signaling goes BAD. Dev Cell 3: 607-608.
47. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, et al. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320: 1-13.
48. Rozenfeld R, Devi LA, Exploring a role for heteromerization in GPCR signalling specificity. Biochem J 433: 11-18.
49. Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, et al. (2008) beta-arrestin-biased agonism at the beta2-adrenergic receptor. J Biol Chem 283: 5669-5676.